Growth equity fund research profile
General Atlantic is a growth-equity investor with a broad India portfolio across financial services, consumer, healthcare and technology. Its approach is to back scaled or scaling category leaders and support expansion through a global operating and sector network.
At a glance
Research profile
Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.
Investment lens
General Atlantic (India) uses a growth equity approach across Fintech, consumer, health, tech services.
Current evidence
General Atlantic’s current India portfolio and public financing coverage identify active and exited India-linked positions including PhonePe, KIMS Hospitals, Capital Foods, BillDesk, CitiusTech, KFin Technologies and 360 ONE; the 2025 PhonePe secondary transaction is included in the current record.
Strategy
Growth equity
Sector focus
Fintech, consumer, health, tech services
AIF structure context
Indian private equity, growth, buyout and many real-asset strategies are commonly structured as Category II AIFs. Verify the specific vehicle and registration before investing.
Current signal
General Atlantic’s current India portfolio and public financing coverage identify active and exited India-linked positions including PhonePe, KIMS Hospitals, Capital Foods, BillDesk, CitiusTech, KFin Technologies and 360 ONE; the 2025 PhonePe secondary transaction is included in the current record.
Investor questions
General Atlantic (India) is covered in Rupeia's private equity research universe. The current public record describes the strategy as Growth equity, with a sector focus of Fintech, consumer, health, tech services. The profile should be read with the linked source trail and Typical route: Category II AIF context.
The profile displays only company or asset names attributable to General Atlantic (India) in the reviewed public sources: PhonePe, NSE, KFin Technologies, TBO, KIMS Hospitals, Capital Foods, Ujala Cygnus. It does not represent a complete current portfolio unless the manager has published one.
General Atlantic’s India portfolio page records PhonePe, Jio, KIMS Hospitals, Capital Foods, PNB Housing Finance, 360 ONE, BillDesk, CitiusTech and others, including exited investments such as Jio, KIMS and Capital Foods. PhonePe separately disclosed $550M from General Atlantic and co-investors in a 2023 tranche; India fund-level returns are not disclosed. These signals are not a substitute for fund- and vintage-specific net performance, realised distributions and audited or administrator-supported reporting.
Public fund size: PhonePe’s disclosed financing brings General Atlantic and co-investors’ cumulative investment to $550M in the cited 2023 round; this is a company exposure, not fund size. General Atlantic does not disclose an India-only AUM figure on the reviewed pages.. Public terms or access information: Growth equity across financial services, technology, healthcare and consumer businesses. India cheque sizes, reserve policy and vehicle-level terms are not consistently disclosed.. Current fees, minimum commitment and availability must be confirmed for the exact named vehicle in its fund documents.
The current source record names Sandeep Naik (India/SEA head). Verify current roles, departures, attribution and key-person provisions before relying on the team history for a new commitment.
Review entry valuation, leverage, governance rights, concentration, execution of the value-creation plan and exit timing. The current open diligence point is: India-specific deployment and post-Actis integrated AUM are not publicly disclosed..
2025: General Atlantic’s current India portfolio and public financing coverage identify active and exited India-linked positions including PhonePe, KIMS Hospitals, Capital Foods, BillDesk, CitiusTech, KFin Technologies and 360 ONE; the 2025 PhonePe secondary transaction is included in the current record.
Next step
Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.